Antibiotic resistance markers are a necessary tool in many clinical areas
Open Access
- 29 December 2020
- journal article
- Published by Publishing Office TRILIST in Reproductive Endocrinology
- No. 56,p. 49-56
- https://doi.org/10.18370/2309-4117.2020.56.49-56
Abstract
Antibiotic resistance (AR) is one of the leading and still far from solving the problems of mankind. Implementation of strategies for controling AR at different levels is a priority task, since crisis of the possibilities of creating new antibiotics is obvious. Implementation of this strategy in the medical field consists in the rational use of antibacterial agents and hygienic control of the spread of multiresistant strains.One of the ways to rationalize the use of antimicrobial agents was WHO AWaRe classification, the purpose of which is to expand the use of narrow-spectrum antibiotics and limit the misuse of reserve groups and drugs with growing resistance levels. Implementation of these tasks is impossible without microbiological studies. Laboratory diagnostics of the infectious causes has undergone significant improvement – automation, availability of routine determination of resistance markers. The review presents the main mechanisms of AR development by common pathogens and possibility of their reflection in resistance markers.An important milestone in 2020 was the Infectious Diseases Society of America (IDSA) clinical guideline for treatment of infectious caused by common multi-resistant gram-negative bacteria. In contrast to previous clinical guidelines, this makes the prescription of antibacterial drugs primarily on information about resistance markers, antibiotic susceptibility, and also on the location of infection. The purpose of the IDSA-2020 clinical guidelines is to assist clinicians in making decisions in treatment of infections caused by extended-spectrum β-lactamase or carbapenemase-producing Enterobacteriaceae bacteria and Pseudomonas feruginosa multi-drug resistant. The review presents the main points of this clinical guideline.Thus, effective treatment of infections caused by antibiotic-resistant microorganisms is possible due to contemporary microbiological methods according to evidence-based clinical guidelines. Automated microbiological research systems significantly expand the clinical possibilities of effective treatment of infections and epidemiological control of resistant strains.Keywords
This publication has 45 references indexed in Scilit:
- Efficacy of tigecycline for the treatment of complicated intra-abdominal infections in real-life clinical practice from five European observational studiesJournal of Antimicrobial Chemotherapy, 2013
- Carbapenem-resistant Enterobacteriaceae: a review of treatment and outcomesDiagnostic Microbiology and Infectious Disease, 2013
- Impact of Cefepime Therapy on Mortality among Patients with Bloodstream Infections Caused by Extended-Spectrum-β-Lactamase-Producing Klebsiella pneumoniae and Escherichia coliAntimicrobial Agents and Chemotherapy, 2012
- Are susceptibility tests enough, or should laboratories still seek ESBLs and carbapenemases directly?Journal of Antimicrobial Chemotherapy, 2012
- Global Spread of Carbapenemase-producingEnterobacteriaceaeEmerging Infectious Diseases, 2011
- International Clinical Practice Guidelines for the Treatment of Acute Uncomplicated Cystitis and Pyelonephritis in Women: A 2010 Update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious DiseasesClinical Infectious Diseases, 2011
- Broad‐Spectrum Antimicrobials and the Treatment of Serious Bacterial Infections: Getting It Right Up FrontClinical Infectious Diseases, 2008
- Pharmacokinetics and pharmacodynamics of the tetracyclines including glycylcyclinesJournal of Antimicrobial Chemotherapy, 2006
- The Efficacy and Safety of Tigecycline for the Treatment of Complicated Intra‐Abdominal Infections: Analysis of Pooled Clinical Trial DataClinical Infectious Diseases, 2005
- In vitro killing of parenteral beta-lactams against standard and high inocula of extended-spectrum beta-lactamase and non-esbl producing klebsiella pneumoniaeDiagnostic Microbiology and Infectious Disease, 2004